These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3139859)

  • 41. Assessment of valproic acid serum-cerebrospinal fluid transport by microdialysis.
    Golden PL; Brouwer KR; Pollack GM
    Pharm Res; 1993 Dec; 10(12):1765-71. PubMed ID: 8302764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study.
    Scism JL; Powers KM; Artru AA; Lewis L; Shen DD
    Brain Res; 2000 Nov; 884(1--2):77-86. PubMed ID: 11082489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.
    Suzuki E; Koyama K; Nakai D; Goda R; Kuga H; Chiba K
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):965-972. PubMed ID: 28447323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears.
    Sato S; Kitagawa S; Nakajima M; Shimada K; Honda A; Miyazaki H
    Pharm Res; 2001 Apr; 18(4):500-9. PubMed ID: 11451038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double Weibull input function describes the complex absorption of sustained-release oral sodium valproate.
    Bressolle F; Gomeni R; Alric R; Royer-Morrot MJ; Necciari J
    J Pharm Sci; 1994 Oct; 83(10):1461-4. PubMed ID: 7884670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
    Gal P; Oles KS; Gilman JT; Weaver R
    Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rapid and highly sensitive UPLC-MS/MS method using pre-column derivatization with 2-picolylamine for intravenous and percutaneous pharmacokinetics of valproic acid in rats.
    Joo KM; Choi D; Park YH; Yi CG; Jeong HJ; Cho JC; Lim KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():35-42. PubMed ID: 24041657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A physiologically based pharmacokinetic model for Valproic acid in adults and children.
    Ogungbenro K; Aarons L;
    Eur J Pharm Sci; 2014 Oct; 63():45-52. PubMed ID: 25010262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.
    Omoda K; Murakami T; Yumoto R; Nagai J; Maeda Y; Kiribayashi Y; Takano M
    J Pharm Sci; 2005 Aug; 94(8):1685-93. PubMed ID: 15986463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
    Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ogawa N
    J Clin Pharmacol; 1989 Nov; 29(11):1048-52. PubMed ID: 2513338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of childhood epilepsy with rectal valproate: case reports and pharmacokinetic study.
    Kanazawa O; Sengoku A; Kawai I
    Brain Dev; 1987; 9(6):615-20. PubMed ID: 3128135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet.
    Garikipati V; Toops DS; Fang Q
    Curr Med Res Opin; 2008 Jul; 24(7):1869-76. PubMed ID: 18593524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous absorption of 1,3-dinitroglycerin and a trial of pharmacokinetic analysis.
    Ogiso T; Iwaki M; Kanokogi A; Terao Y
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2829-33. PubMed ID: 2127557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat.
    Neau B; Roux J; Courtiol C; Lambrey B; Marty JP
    Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.
    Tang W; Palaty J; Abbott FS
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1163-72. PubMed ID: 9316822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodium.
    Reed RC; Dutta S
    Am J Health Syst Pharm; 2004 Nov; 61(21):2284-9. PubMed ID: 15552636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.